- Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis
-
Ko KD, Cho BL
- KMID: 2188301
- J Korean Geriatr Soc.
- 2012 Dec;16(4):233-236.
- doi: 10.4235/jkgs.2012.16.4.233
Osteoporosis is the most common metabolic bone disease that results in an increased risk of fragility fractures. Bisphosphonates are commonly used in the treatment of osteoporosis. Concerns about their association... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Vitamin K2 in Addition to Risedronate on the Patients with Postmenopausal Osteoporosis
-
Kim SB, Ryoo KH, Lee KW, Kwak H, Yoon K
- KMID: 2178460
- J Korean Acad Rehabil Med.
- 2006 Oct;30(5):491-495.
OBJECTIVE: To assess the effect of vitamin K2 in addition to risedronate on postmenopausal osteoporosis METHOD: We enrolled 21 postmenopausal osteoporosis women (age: 65.2+/-7.8 years). Ten subjects received risedronate (35 mg,... -
- CITED
-
- Close
- SHARE
-
- Close
- Protective effect of glucosamine and risedronate (alone or in combination) against osteoarthritic changes in rat experimental model of immobilized knee
-
Salman A, Shabana AI, El-ghazouly DEs, Maha E
- KMID: 2466704
- Anat Cell Biol.
- 2019 Dec;52(4):498-510.
- doi: 10.5115/acb.19.050
This study is aiming to investigate the protective effect of glucosamine, risedronate (alone or in combination) on articular cartilage in experimental model of immobilized rat knee. Twenty-five adult male albino... -
- CITED
-
- Close
- SHARE
-
- Close
- The Comparision of Mitigative Effect of Alendronate and Risedronate on Particle-Induced Osteolysis: in Mouse Calvarian Model
-
Lee DS, Choi NY, Nah KH, Song HS, Do JH, Han SK
- KMID: 2199069
- J Korean Orthop Res Soc.
- 2008 Apr;11(1):1-10.
PURPOSE: The purpose of this study was to compare the mitigative effect of alendronate and risedronate on osteolysis in the mouse calvarian model by using titanium (Ti) and polymethylmethacrylate (PMMA)... -
- CITED
-
- Close
- SHARE
-
- Close
- Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
-
Kamimura M, Nakamura Y, Ikegami S, Komatsu M, Uchiyama S, Kato H
- KMID: 2368635
- Osteoporos Sarcopenia.
- 2016 Sep;2(3):170-174.
- doi: 10.1016/j.afos.2016.07.002
As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of New Vertebral Fractures after Treatment with Risedronate, Alendronate or Calcium Carbonate in Patients with Osteoporotic Compression Fracture Treated with Cement Augmentation
-
Kim JY, Moon ES, Lee HM, Moon SH, Park JO, Hyung JH, Kim HS
- KMID: 2336206
- J Korean Orthop Assoc.
- 2009 Aug;44(4):436-441.
PURPOSE: To evaluate the rate of new fractures of the spine after risedronate, alendronate or calcium carbonate in patients who had vertebroplasty or kyphoplasty due to compression fracture. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents
-
Kim S, Bang HH, Yoo H, Park IH, Yang KH, Lim H, Jung WS
- KMID: 2165122
- J Bone Metab.
- 2016 May;23(2):85-93.
- doi: 10.11005/jbm.2016.23.2.85
BACKGROUND: To retrospectively assess whether the response of subtrochanteric lateral cortex (STLC) is different according to the bisphosphonate agents in terms of bone mineral density (BMD) change. METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Osteonecrosis of the Jaw in a Patient with Osteoporosis Treated with Oral Bisphosphonates
-
Choi SW, Kim SR, Lee KB, Nam KW, Seo KB, Nam U, Kim HJ
- KMID: 2185584
- J Korean Orthop Assoc.
- 2010 Apr;45(2):151-154.
- doi: 10.4055/jkoa.2010.45.2.151
Bisphosphonates are widely used in the management of metastatic bone disease and in the prevention of osteomalacia and osteoporosis. In particular, oral preparations are more commonly used for the prevension... -
- CITED
-
- Close
- SHARE
-
- Close
- Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
-
Nho JH, Lee YK, Ha YC, Kim CH, Suh YS, Koo KH
- KMID: 2165118
- J Bone Metab.
- 2016 May;23(2):51-54.
- doi: 10.11005/jbm.2016.23.2.51
BACKGROUND: Although bisphosphonate is effective for the prevention and treatment of osteoporosis, poor medication compliance is a key-limiting factor. We determined whether alarm clock could improve compliance with weekly bisphosphonate... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Treatment of Osteoporosis
-
Byun DW
- KMID: 2183506
- J Korean Med Assoc.
- 2004 Sep;47(9):889-894.
- doi: 10.5124/jkma.2004.47.9.889
Osteoporosis is a common and significant health problem in more than 1/3 of postmenopausal women. Strategies for the medical treatment of osteoporosis are primarily based on decreasing the resorption component... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Risedronate on Posterior Lateral Spinal Fusion in a Rat Model
-
Gezici AR, Ergun R, Gurel K, Yilmaz F, Okay O, Bozdogan O
- KMID: 2189885
- J Korean Neurosurg Soc.
- 2009 Jul;46(1):45-51.
- doi: 10.3340/jkns.2009.46.1.45
OBJECTIVE: To evaluate the potential effects of risedronate (RIS) which shows a higher anti-resorptive effect among bisphosphonates, after a posterolateral lumbar intertransverse process spinal fusion using both autograft and allograft... -
- CITED
-
- Close
- SHARE
-
- Close
- Cost-effectiveness of Pharmaceutical Interventions to Prevent Osteoporotic Fractures in Postmenopausal Women with Osteopenia
-
Kwon JW, Park HY, Kim YJ, Moon SH, Kang HY
- KMID: 2165120
- J Bone Metab.
- 2016 May;23(2):63-77.
- doi: 10.11005/jbm.2016.23.2.63
BACKGROUND: To assess the cost-effectiveness of drug therapy to prevent osteoporotic fractures in postmenopausal women with osteopenia in Korea. METHODS: A Markov cohort simulation was conducted for lifetime with a hypothetical... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Vitamin D Deficiency with Secondary Hyperparathyroidism and Brown Tumor
-
Lee MK, Kang WS, Kim TH, Lee JH, Kim SH
- KMID: 2314121
- Osteoporosis.
- 2012 Aug;10(2):90-96.
The importance of vitamin D for skeletal health is well known. Vitamin D deficiency causes secondary hyperparathyroidism, high bone turnover, bone loss, and osteoporotic fractures. We report a case of... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?
-
Ohtori S, Orita S, Yamauchi K, Eguchi Y, Aoki Y, Nakamura J, Suzuki M, Kubota G, Inage K, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue M, Kinoshita , Furuya T, Koda M
- KMID: 2377761
- Asian Spine J.
- 2017 Apr;11(2):272-277.
- doi: 10.4184/asj.2017.11.2.272
STUDY DESIGN: Retrospective case series. PURPOSE: The purpose of this study was to determine whether discontinuing teriparatide treatment and replacing it with bisphosphonate treatment maintains the volume of the fusion mass... -
- CITED
-
- Close
- SHARE
-
- Close
- Subsequent Hip Fracture in Osteoporotic Hip Fracture Patients
-
Lee SH, Lee TJ, Cho KJ, Shin SH, Moon KH
- KMID: 2453960
- Yonsei Med J.
- 2012 Sep;53(5):1005-1009.
PURPOSE: A significant number of patients who have experienced previous surgical treatment for an osteoporotic hip fracture experience a subsequent hip fracture (SHF) on the opposite side. This study aims... -
- CITED
-
- Close
- SHARE
-
- Close
- Subsequent Hip Fracture in Osteoporotic Hip Fracture Patients
-
Kim HS, Lee SH, Moon KH
- KMID: 2314084
- Osteoporosis.
- 2010 Dec;8(3):297-302.
OBJECTIVES: A significant number of patients who had a previous surgical treatment in the hip area experience subsequent hip fracture (SHF) on the opposite side. This study aims to analyze... -
- CITED
-
- Close
- SHARE
-
- Close
- An Experimental Study on Bisphosphonates Ototoxicity
-
Park IS, Kim HJ, Lim HJ
- KMID: 2274403
- Korean J Otolaryngol-Head Neck Surg.
- 1998 Mar;41(3):307-312.
BACKGROUND AND OBJECTIVES: Bisphosphonates are known to inhibit bone resorption, and some researchs are also undergoing on their protective effect against localized bone resorprion in aural cholesteatoma. However, ototoxicity has... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw
-
Kang MH, Lee DK, Kim CW, Song IS, Jun SH
- KMID: 2430583
- J Korean Assoc Oral Maxillofac Surg.
- 2018 Oct;44(5):225-231.
- doi: 10.5125/jkaoms.2018.44.5.225
OBJECTIVES: The purpose of this study was to investigate the demographic and clinical characteristics of patients with medication-related osteonecrosis of the jaw (MRONJ) and to elucidate factors affecting recurrence in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of bisphosphonate combined with activated vitamin D in patients with aromatase inhibitor-induced osteoporosis after breast cancer operation
-
Tanaka M, Itoh S, Takeuchi Y
- KMID: 2437291
- Osteoporos Sarcopenia.
- 2018 Sep;4(3):111-117.
- doi: 10.1016/j.afos.2018.08.002
OBJECTIVES: We compared the effectiveness of bisphosphonates combined with activated vitamin D administered for therapy of aromatase inhibitor-induced osteoporosis after a breast cancer operation and primary postmenopausal osteoporosis through propensity... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the efficacy of three once-weekly bisphosphonates on bone mineral density gains in Korean women
-
Lee JH, Jee BC, Suh CS, Kim SH, Choi YM, Kim JG, Moon SY
- KMID: 2313945
- Obstet Gynecol Sci.
- 2013 May;56(3):176-181.
OBJECTIVE: To assess the efficacies of once-weekly bisphosphonates on bone mineral density (BMD) gains in Korean women aged 50 years or more. METHODS: We selected 166 patients who received: alendronate 70... -
- CITED
-
- Close
- SHARE
-
- Close
